Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan

References

• Gatta G, Rossi S, Foschi R, et al. Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. Haematologica. 2013;98:744–752.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981–2005. Cancer. 2009;115:4973–4979.
   PubMed Web of Science ®Google Scholar
• Douer D, DeAngelo DJ, Advani A, et al. Applying pediatric therapeutic strategies to adults with acute lymphoblastic leukemia and lymphoma. II. Comparison with adult treatment regimens, including hyper-CVAD. Am Oncol Hemat Rev. 2014:47–53.
   Google Scholar
• Pinkerton R, Wills RA, Coory MD, et al. Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age-related gap narrowing? Med J Aust. 2010;193:217–221.
   PubMed Web of Science ®Google Scholar
• Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003;21:774–780.
   PubMed Web of Science ®Google Scholar
• Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer. 2007;48:254–261.
   PubMed Web of Science ®Google Scholar
• Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children’s Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112:1646–1654.
   PubMed Web of Science ®Google Scholar
• Huguet F, Leguay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27:911–918.
   PubMed Web of Science ®Google Scholar
• Ribera JM, Oriol A, Sanz MA, et al. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96. J Clin Oncol. 2008;26:1843–1849.
   PubMed Web of Science ®Google Scholar
• Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol. 2007;25:813–819.
   PubMed Web of Science ®Google Scholar
• Hayakawa F, Sakura T, Yujiri T, et al. Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group. Blood Cancer J. 2014;4:e252.
   PubMed Web of Science ®Google Scholar
• Ram R, Wolach O, Vidal L, et al. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis. Am J Hematol. 2012;87:472–478.
   PubMed Web of Science ®Google Scholar
• Stock W, Luger SM, Advani AS, et al. Favorable outcomes for older adolescents and young adults with acute lymphoblastic leukemia: early results of U.S. Intergroup Trial C10403. Blood (Suppl). 2014;124:796.
   Web of Science ®Google Scholar
• SEER Program. 2012. SEER original AYA Site Recode. Accessed January 14, 2015 from: http://seer.cancer.gov/ayarecode/ayarecode-orig.html
   Google Scholar
• Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006;106:1425–1430.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Yumura-Yagi K, Yoshida M, et al. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol. Pediatr Blood Cancer. 2010;54:71–78.
   PubMed Web of Science ®Google Scholar
• Wood WA, Lee SJ. Malignant hematologic diseases in adolescents and young adults. Blood. 2011;117:5803–5815.
   PubMed Web of Science ®Google Scholar
• Fern LA, Lewandowski JA, Coxon KM, Whelan J; National Cancer Research Institute Teenage and Young Adult Clinical Studies Group, UK. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. Lancet Oncol. 2014;15:e341–e350.
   PubMed Web of Science ®Google Scholar
• Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol. 2009;144:147–156.
   PubMed Web of Science ®Google Scholar
• Chiaretti S, Vitale A, Cazzaniga G, et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica. 2013;98:1702–1710.
   PubMed Web of Science ®Google Scholar
• Schwab CJ, Chilton L, Morrison H, et al. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica. 2013;98:1081–1088.
   PubMed Web of Science ®Google Scholar
• Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371:1005–1015.
   PubMed Web of Science ®Google Scholar
• Tewari P, Franklin AR, Tarek N, et al. Hematopoietic stem cell transplantation in adolescents and young adults. Acta Haematol. 2014;132:313–325.
   PubMed Web of Science ®Google Scholar
• Hochberg J, Khaled S, Forman SJ, et al. Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission. Br J Haematol. 2013;161:27–42.
   PubMed Web of Science ®Google Scholar
• Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107:1645–1655.
   PubMed Web of Science ®Google Scholar
• Kmietowicz Z. Teenagers and young adults with cancer need better access to clinical trials. BMJ. 2013;346:f1959
   PubMed Web of Science ®Google Scholar
• Ferrari A, Aricò M, Dini G, et al. Upper age limits for accessing pediatric oncology centers in Italy: a barrier preventing adolescents with cancer from entering national cooperative AIEOP trials. Pediatr Hematol Oncol. 2012;29:55–61.
   PubMed Web of Science ®Google Scholar
• Bleyer A. Adolescent and young adult (AYA) oncology: the first A. Pediatr Hematol Oncol. 2007;24:325–336.
   PubMed Web of Science ®Google Scholar
• DeAngelo DJ, Stevenson KE, Dahlberg SE, et al. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia. 2015;29:526–534.
   PubMed Web of Science ®Google Scholar
• Baba S, Ioka A, Tsukuma H, et al. Incidence and survival trends for childhood cancer in Osaka, Japan, 1973-2001. Cancer Sci. 2010;101:787–792.
   PubMed Web of Science ®Google Scholar
• Parsons HM, Harlan LC, Seibel NL, et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol. 2011;29:4045–4053.
   PubMed Web of Science ®Google Scholar
• Adolescent and Young Adult Oncology Progress Review Group. Closing the Gap: research and care imperatives for adolescents and young adults with cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. U. S. Department of Health and Human Services, National Institutes of Health, National Cancer Institutes and the LIVESTRONG Young Adults Alliance. NIH Publication No.06-6067, 2006: 3–17.
   Google Scholar
• Canner J, Alonzo TA, Franklin J, et al. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children’s Oncology Group. Cancer. 2013;119:4162–4169.
   PubMed Web of Science ®Google Scholar
• Woods WG, Franklin AR, Alonzo TA, et al. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials. Cancer. 2013;119:4170–4179.
   PubMed Web of Science ®Google Scholar